Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2003
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003EP1347759A1 Antibacterial compounds
10/01/2003EP1105393B1 Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
10/01/2003EP0970079B1 Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles
10/01/2003EP0772596B1 INDOLIZINE sPLA2 INHIBITORS
10/01/2003CN1446219A Liquid crystalline-3, 4:9, 10-perylenetetracarboxylic acid diimides
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446217A Beta-carboline derivatives useful as inhibitors of phosphodiesterase
10/01/2003CN1445227A Method for extracting total alkaloid of corydalis rhizome and its new usage
10/01/2003CN1122667C Process for preparing N6-substituted deaza adenosine derivatives
10/01/2003CN1122665C Herbicidal N-alkenyl heteroaryloxyacetamides
09/2003
09/30/2003US6627756 Vaporization, crystallization, purification
09/30/2003US6627753 Agricultural insecticides
09/30/2003US6627653 Anticonvulsant derivatives useful for the treatment of depression
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627636 Benzo(3,4)pyrido(3,2-a)cycloctenes and benzo(3,4)pyrido-(3,2-a)oxocins, -thiocins or azocines; anticholesterol, antilipemic agents; lowering LDL cholesterol; increasing HDl cholesterol; hypertriglyceridemia and atherosclerosis
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/30/2003US6627624 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome,
09/30/2003CA2112982C Process for the preparation of optical isomers of a amino-2-napththyridine derivative
09/30/2003CA2112980C Process for the preparation of the dextrogyral isomer of a isoindolinone derivative
09/30/2003CA2112979C Novel derivative of amino-2-naphthyridine, preparation and use thereof
09/25/2003WO2003078541A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078434A1 Ethane-1,2-diamino-bis[(2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
09/25/2003WO2003078433A1 Process for preparing crystalline form i of cabergoline
09/25/2003WO2003078432A2 Process for the synthesis of pergolide
09/25/2003WO2003078427A1 Azolylaminoazines as inhibitors of protein kinases
09/25/2003WO2003078426A1 Azolylaminoazine as inhibitors of protein kinases
09/25/2003WO2003078423A1 Compositions useful as inhibitors of protein kinases
09/25/2003WO2003078402A1 Indazoles substituted with an anti-cancerous activity
09/25/2003WO2003078392A2 Process for preparing crystalline form i of cabergoline
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077918A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
09/25/2003WO2003077857A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
09/25/2003WO2003077850A2 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2002080911A3 Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments for the treatment of neurodegenerative diseases
09/25/2003US20030181722 An immunosuppressants for treating autoimmune diseases, antiallergic agents, antitumor agents
09/25/2003US20030181721 Liquid crystalline 3,4:9,10-perylenetetacarbocylic acid diimides
09/25/2003US20030181719 Novel heterocyclic antibacterial compounds
09/25/2003US20030181508 For therapy of attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181496 Having Transforming Growth Factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues
09/25/2003US20030181480 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds
09/25/2003US20030181470 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
09/25/2003US20030181466 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
09/25/2003US20030181465 Pyrimidines as novel openers of potassium ion channels
09/25/2003US20030181463 Antiviral azaindole derivatives
09/25/2003US20030181458 Preferential serotonin receptors antagonists comprising heterocyclic amines used for prophylaxis or prevention of headaches, sleep, sexual or eating disorders and as antidepressants
09/25/2003US20030181457 Tertiary amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular and sexual disorders
09/25/2003US20030181455 Bicyclic and tricyclic hetroaromatic compounds
09/25/2003US20030181449 Methods and compositions for the treatment of pain
09/25/2003US20030181446 Novel N-acylated heterocycles
09/25/2003US20030181438 Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
09/25/2003US20030181420 Modulators of LXR
09/25/2003CA2479620A1 Ethane-1,2-diamino-bis[2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
09/25/2003CA2479140A1 Process for preparing crystalline form i of cabergoline
09/25/2003CA2478715A1 Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators
09/25/2003CA2478540A1 Indazoles substituted with an anti-cancerous activity
09/25/2003CA2478310A1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors
09/25/2003CA2478149A1 Process for preparing crystalline form i of cabergoline
09/24/2003EP1346994A1 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345938A1 Tricyclic crf receptor antagonists
09/24/2003EP1345937A1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1272489B1 Process for preparing crystalline form i of cabergoline
09/24/2003EP1265898B1 1,8-NAPHTHALIMIDE IMIDAZO 4,5,1- i de /i ]ACRIDONES WITH ANTI-TUMOR ACTIVITY
09/24/2003EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
09/24/2003EP1224186B1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/24/2003EP1165558B1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444481A Protease inhibitors
09/24/2003CN1122032C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/23/2003US6624317 Taxoid conjugates as antimitotic and antitumor agents
09/23/2003US6624305 Reacting a 6H-imidazo(4,5-c) tetrazolo(1,5-a)quinoline with triphenylphosphine and hydrolyzing
09/23/2003US6624187 Long wave length absorbing bacteriochlorin alkyl ether analogs
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624171 Useful as cyclin dependent kinase 11 inhibitors, for preventing/reducing the severity of epithelial cytotoxicity side-effects (e.g., alopecia, plantar- palmar syndrome, mucositis) induced by chemotherapy and/or radiation therapy
09/23/2003US6624162 5-HT4 receptor binding activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, Functional dyspepsia, irritable bowel syndrome or the like in mammalian, especially humans.
09/23/2003US6624159 Herpes virus
09/23/2003US6623930 Contacting cell with non-nucleoside compounds that interact with specific DNA structures and which inhibit human telomerase reducing proliferative capacity of a cell
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/23/2003CA2072814C Benzomorphans and their use as pharmaceutical compositions
09/23/2003CA2066807C Contraception in female primates without affecting the menstrual cycle
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076442A1 Purine derivatives as kinase inhibitors
09/18/2003WO2003076440A1 Condensed heterocyclic compounds as calcitonin agonists
1 ... 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 ... 646